메뉴 건너뛰기




Volumn 14, Issue 8, 2008, Pages 756-767

Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIOBESITY AGENT; ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MEGLITINIDE; NEUROLEPTIC AGENT; NICOTINIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; PROGESTERONE; STEROID; SULFONYLUREA; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; VASODILATOR AGENT;

EID: 56049122937     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2008.14.8.756     Document Type: Article
Times cited : (10)

References (25)
  • 1
    • 33644849222 scopus 로고    scopus 로고
    • Heart disease and stroke statistics - 2006 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Available at:, Accessed September 8, 2008
    • Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics - 2006 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85-151. Available at: http://circ.ahajournals.org/cgi/ content/short/113/6/e85. Accessed September 8, 2008.
    • (2006) Circulation , vol.113 , Issue.6
    • Thom, T.1    Haase, N.2    Rosamond, W.3
  • 2
    • 17144380822 scopus 로고    scopus 로고
    • The metabolic syndrome
    • Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-28.
    • (2005) Lancet , vol.365 , Issue.9468 , pp. 1415-1428
    • Eckel, R.H.1    Grundy, S.M.2    Zimmet, P.Z.3
  • 3
    • 3042700220 scopus 로고    scopus 로고
    • Metabolic syndrome: Time for action
    • Deen D. Metabolic syndrome: time for action. Am Fam Physician. 2004; 69(12):2875-82.
    • (2004) Am Fam Physician , vol.69 , Issue.12 , pp. 2875-2882
    • Deen, D.1
  • 4
    • 22844436649 scopus 로고    scopus 로고
    • Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults
    • Ford ES, Kohl HW 3rd, Mokdad AH, Ajani UA. Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults. Obes Res. 2005;13(3):608-14.
    • (2005) Obes Res , vol.13 , Issue.3 , pp. 608-614
    • Ford, E.S.1    Kohl 3rd, H.W.2    Mokdad, A.H.3    Ajani, U.A.4
  • 5
    • 33748793977 scopus 로고    scopus 로고
    • Insurance coverage for obesity treatment
    • Tsai AG, Asch DA, Wadden TA. Insurance coverage for obesity treatment. J Am Diet Assoc. 2006;106(10):1651-55.
    • (2006) J Am Diet Assoc , vol.106 , Issue.10 , pp. 1651-1655
    • Tsai, A.G.1    Asch, D.A.2    Wadden, T.A.3
  • 6
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Knowler WC, Barrett-Connor E, Fowler SF, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
    • (2002) N Engl J Med , vol.346 , Issue.6 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.F.3
  • 7
    • 36049005288 scopus 로고    scopus 로고
    • Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: Analysis using claims, laboratory, and medical record data
    • Yu AP, Wu EQ, Birnbaum HG, et al. Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data. Curr Med Res Opin. 2007;23(9):2157-69.
    • (2007) Curr Med Res Opin , vol.23 , Issue.9 , pp. 2157-2169
    • Yu, A.P.1    Wu, E.Q.2    Birnbaum, H.G.3
  • 8
    • 33845764795 scopus 로고    scopus 로고
    • Is it time for managed care organizations to cover weight reduction?
    • Fine M. Is it time for managed care organizations to cover weight reduction? Value Health. 2007;10(Suppl):S2-S3.
    • (2007) Value Health , vol.10 , Issue.SUPPL.
    • Fine, M.1
  • 9
    • 0037992871 scopus 로고    scopus 로고
    • National trends in antiobesity medication use
    • Available at:, Accessed September 16, 2008
    • Stafford RS, Radley DC. National trends in antiobesity medication use. Arch Intern Med. 2003;163(9):1046-50. Available at: http://archinte.ama-assn.org/cgi/reprint/163/9/1046. Accessed September 16, 2008.
    • (2003) Arch Intern Med , vol.163 , Issue.9 , pp. 1046-1050
    • Stafford, R.S.1    Radley, D.C.2
  • 10
    • 0033823226 scopus 로고    scopus 로고
    • National patterns of physician activities related to obesity management
    • Stafford RS, Farhat JH, Misra B, Schoenfeld DA. National patterns of physician activities related to obesity management. Arch Fam Med. 2000; 9(7):631-38.
    • (2000) Arch Fam Med , vol.9 , Issue.7 , pp. 631-638
    • Stafford, R.S.1    Farhat, J.H.2    Misra, B.3    Schoenfeld, D.A.4
  • 11
    • 0004079106 scopus 로고    scopus 로고
    • Adult Treatment Panel III. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute;, Available at:, Accessed September 15, 2008
    • National Institutes of Health. Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2002. Available at: www.nhlbi.nih.gov/guidelines/ cholesterol/atp3_rpt.htm. Accessed September 15, 2008.
    • (2002) Detection, Evaluation and Treatment of High Blood Cholesterol in Adults
  • 12
    • 29944436303 scopus 로고    scopus 로고
    • IDF Clinical Guidelines Task Force, Brussels: International Diabetes Federation;
    • IDF Clinical Guidelines Task Force. Global Guidelines for Type 2 Diabetes. Brussels: International Diabetes Federation; 2005.
    • (2005) Global Guidelines for Type 2 Diabetes
  • 13
    • 0346244045 scopus 로고    scopus 로고
    • Waist circumference, waist-hip ratio, and body mass index and their correlation with cardiovascular disease risk factors in Australian adults
    • Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio, and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254(6):555-63.
    • (2003) J Intern Med , vol.254 , Issue.6 , pp. 555-563
    • Dalton, M.1    Cameron, A.J.2    Zimmet, P.Z.3
  • 14
    • 0036730862 scopus 로고    scopus 로고
    • Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study
    • Han TS, Williams K, Sattar N, Hunt KJ, Lean ME, Haffner SM. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res. 2002;10(9):923-31.
    • (2002) Obes Res , vol.10 , Issue.9 , pp. 923-931
    • Han, T.S.1    Williams, K.2    Sattar, N.3    Hunt, K.J.4    Lean, M.E.5    Haffner, S.M.6
  • 15
    • 0035515438 scopus 로고    scopus 로고
    • Does waist circumference add to the predictive power of the body mass index for coronary risk?
    • Iwao S, Iwao N, Muller DC, Elahi D, Shimokata H, Andres R. Does waist circumference add to the predictive power of the body mass index for coronary risk? Obes Res. 2001;9(11):685-95.
    • (2001) Obes Res , vol.9 , Issue.11 , pp. 685-695
    • Iwao, S.1    Iwao, N.2    Muller, D.C.3    Elahi, D.4    Shimokata, H.5    Andres, R.6
  • 16
    • 9444223284 scopus 로고    scopus 로고
    • Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calcium
    • Snell-Bergeon JK, Hokanson JE, Kinney GL, et al. Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calcium. Int J Obes Relat Metab Disord. 2004; 28(12):1594-99.
    • (2004) Int J Obes Relat Metab Disord , vol.28 , Issue.12 , pp. 1594-1599
    • Snell-Bergeon, J.K.1    Hokanson, J.E.2    Kinney, G.L.3
  • 17
    • 85036897515 scopus 로고    scopus 로고
    • National Institutes of Health. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute publication number 98-4083; 1998. Available at: www.nhlbi.nih.gov/guidelines/obesity/ ob_gdlns.pdf. Accessed September 8, 2008.
    • National Institutes of Health. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute publication number vol 98-4083; 1998. Available at: www.nhlbi.nih.gov/guidelines/obesity/ ob_gdlns.pdf. Accessed September 8, 2008.
  • 19
    • 0037048167 scopus 로고    scopus 로고
    • Overweight and obesity as determinants of cardiovascular risk: The Framingham experience
    • Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002; 162(16):1867-72.
    • (2002) Arch Intern Med , vol.162 , Issue.16 , pp. 1867-1872
    • Wilson, P.W.1    D'Agostino, R.B.2    Sullivan, L.3    Parise, H.4    Kannel, W.B.5
  • 20
    • 0030637612 scopus 로고    scopus 로고
    • Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans - a 7-year prospective study
    • Wei M, Gaskill SF, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans - a 7-year prospective study. Obes Res. 1997;5(1):16-23.
    • (1997) Obes Res , vol.5 , Issue.1 , pp. 16-23
    • Wei, M.1    Gaskill, S.F.2    Haffner, S.M.3    Stern, M.P.4
  • 21
    • 36248990194 scopus 로고    scopus 로고
    • Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women
    • Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol. 2007; 100(11):1654-58.
    • (2007) Am J Cardiol , vol.100 , Issue.11 , pp. 1654-1658
    • Song, Y.1    Manson, J.E.2    Meigs, J.B.3    Ridker, P.M.4    Buring, J.E.5    Liu, S.6
  • 22
    • 33845739290 scopus 로고    scopus 로고
    • Predicting the prevalence of cardiometabolic risk factors when clinical data are limited
    • Hollenbeak CS, Spackman DE, Ben-Joseph RH, et al. Predicting the prevalence of cardiometabolic risk factors when clinical data are limited. Value Health. 2007;10(Suppl):S4-S11.
    • (2007) Value Health , vol.10 , Issue.SUPPL.
    • Hollenbeak, C.S.1    Spackman, D.E.2    Ben-Joseph, R.H.3
  • 24
    • 17644365734 scopus 로고    scopus 로고
    • The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus
    • Godley PJ, Maue SK, Farrelly EW, Frech F. The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus. Am J Manag Care. 2005;11(4):206-10.
    • (2005) Am J Manag Care , vol.11 , Issue.4 , pp. 206-210
    • Godley, P.J.1    Maue, S.K.2    Farrelly, E.W.3    Frech, F.4
  • 25
    • 57749203180 scopus 로고    scopus 로고
    • Rimonabant for the Treatment of Overweight and Obese Adults
    • National Institute for Health and Clinical Excellence, June, Available at:, Accessed September 15, 2008
    • National Institute for Health and Clinical Excellence. Rimonabant for the Treatment of Overweight and Obese Adults. National Health Service. NICE Technology Appraisal Guidance 144. June 2008. Available at: www.nice.org.uk/nicemedia/pdf/TA144Guidance.pdf. Accessed September 15, 2008.
    • (2008) National Health Service. NICE Technology Appraisal Guidance , vol.144


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.